Abstract
Thiourea derivatives (6a-e) were developed and screened for antitumor and anti-inflammatory activity. Most of the compounds exhibited growth inhibitory effects comparable to 5-fluorouracil in vitro against mammary (MCF-7 and MDA-MB 231) as well as colon (HT-29) carcinoma cells. They also showed stronger anti-inflammatory activity than ibuprofen in vivo in the xylene-induced ear swelling assay in mice.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / chemical synthesis*
-
Anti-Inflammatory Agents / chemistry
-
Anti-Inflammatory Agents / pharmacology
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Biological Assay
-
Breast Neoplasms / drug therapy*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Colonic Neoplasms / drug therapy*
-
Cyclization
-
Disease Models, Animal
-
Drug Design*
-
Female
-
Humans
-
Inhibitory Concentration 50
-
Mice
-
Pyrimidines / chemical synthesis*
-
Pyrimidines / chemistry
-
Pyrimidines / pharmacology
-
Thiourea / chemical synthesis*
-
Thiourea / chemistry
-
Thiourea / pharmacology
Substances
-
Anti-Inflammatory Agents
-
Antineoplastic Agents
-
Pyrimidines
-
Thiourea